Back to Search
MARK H BACKLUND MD
MD
Psychiatry Physician
NPI: 1306883152Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
MD00015319(WA)
Research & Publications (20)
Targeting the eicosanoid pathway in non-small-cell lung cancer.
PMID 19409031·Expert Opin Ther Targets·2009
6-review
Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.
PMID 19246543·Nucleic Acids Res·2009
8-other
Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis.
PMID 19010439·Prostaglandins Other Lipid Mediat·2009
7-preclinical
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
PMID 18676872·Cancer Res·2008
7-preclinical
Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.
PMID 18445660·Mol Cancer Ther·2008
8-other
Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
PMID 18281650·J Clin Oncol·2008
8-other
Unexpected C-H activation of Ru(II)-dithiomaltol complexes upon oxidation.
PMID 18257546·Inorg Chem·2008
8-other
Regulation of prostaglandin transporters in colorectal neoplasia.
PMID 19138942·Cancer Prev Res (Phila)·2008
7-preclinical
Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
PMID 19010907·Cancer Res·2008
7-preclinical
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
PMID 17493263·Genome Biol·2007
4-observational
Interactions of polybrominated diphenyl ethers with the aryl hydrocarbon receptor pathway.
PMID 16601081·Toxicol Sci·2006
7-preclinical
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
PMID 16818638·Cancer Res·2006
7-preclinical
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.
PMID 15451023·Cell Signal·2005
7-preclinical
Mechanisms of disease: Inflammatory mediators and cancer prevention.
PMID 16264935·Nat Clin Pract Oncol·2005
6-review
Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
PMID 16210874·Oncology·2005
6-review
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.
PMID 16100121·J Biol Chem·2005
7-preclinical
15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
PMID 15542609·J Biol Chem·2005
7-preclinical
Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.
PMID 14975754·Biochem Biophys Res Commun·2004
7-preclinical
Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
PMID 14742684·Mol Pharmacol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1103 CLEVELAND AVE
MOUNT VERNON, WA 98273 - Phone
- (360) 336-6868
Quick Facts
- NPI
- 1306883152
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile